June 24, 2022 News by Marta Figueiredo, PhD NICE Updates Its Guidelines for MS Management The National Institute for Health and Care Excellence (NICE) in England has updated its guidelines for the diagnosis and management of adults with multiple sclerosisĀ (MS). Called Multiple sclerosis in adults: management, the new guidelines update and replace the 2014 recommendations and are meant to be followed by…
November 19, 2021 News by Patricia Inacio, PhD MS Society of Canada Urges Consistent Access to COVID-19 Boosters The Multiple Sclerosis Society of Canada is urging that all provinces and territories in Canada offer COVID-19Ā booster vaccines to at-risk populations, including people who are moderately to severely immunocompromised and multiple sclerosis (MS) patients. In letters sent earlier this month, in collaboration with 11 other health charities, the…
October 8, 2021 Columns by Jamie Hughes Curing Headaches, Pain, and Stress, One Gizmo at a Time Though I have fewer headaches than I used to thanks to acupuncture, I can usually count on at least one whammer a month. While I do take my fair share of over-the-counter pain pills, I donāt like taking copious amounts of medication for obvious reasons. So, Iām always on…
February 10, 2021 News by Joana Carvalho, PhD Progressive MS Alliance Wants Changes to Trials to Better Realize Treatments Making clinical trials more comparable, consistent, and focused on the biological mechanisms underlying the onset and development of multiple sclerosis (MS) are all key to more quickly realizing new treatments for progressive MS, according to the International Progressive MS Alliance. To attain these goals, the Alliance, a worldwide…
November 13, 2020 News by Joana Carvalho, PhD Bone Marrow Transplant Most Useful for Younger Patients, MS Society Experts Suggest A bone marrow transplant may be particularly useful for those with relapsing forms of multiple sclerosis (MS) who, despite treatment with high-efficacy disease-modifying therapies (DMTs), continue to experience relapses or show signs of new lesions, experts say. According to new recommendations from the National Multiple Sclerosis Society,…
October 2, 2020 News by Patricia Inacio, PhD MS Patients Should Avoid ‘Silver’ Tooth Fillings Due to Mercury, FDA Advises People with multiple sclerosis (MS) are among theĀ high-risk groups advised to avoid dental amalgams āĀ silver-colored fillings that are 50% mercury ā underĀ new recommendations issued by theĀ U.S. Food and Drug AdministrationĀ (FDA). Amalgams can be used by dentists to restore the structure and surfaces of teeth damaged by decay.
November 5, 2019 News by Ana Pena PhD EMA Safety Group Advises Lemtrada Be Limited to ‘Highly Active’ RRMS Patients at Hospitals with ICUs Seven months after starting a safety review of Lemtrada (alemtuzumab), the Pharmacovigilance Risk…
May 28, 2019 News by Joana Carvalho, PhD IPMSSG Issues Guidelines on Participation of MS Youngsters in Clinical Trials The International Pediatric Multiple Sclerosis Study Group (IPMSSG) has updated its guidelines regarding the participation of children and adolescents with multiple sclerosis (MS) in clinical trials. The new series of guidelines were published recently inĀ Neurology, the journal of theĀ American Academy of NeurologyĀ (AAN), in an article titled…
January 10, 2018 News by Alice MelĆ£o, MSc Extavia Is the Only Therapy for MS with Relapses That Britain Should Cover, Board Says A British board that recommends what treatments the National Health ServiceĀ should cover has advised the system to use onlyĀ Extavia (interferon beta 1b) as a treatment for MS patients who continue to have relapses. Cost was at the heart of the National Institute for Health and Care…
November 8, 2017 Columns by Judy Lynn Show Your Immune System Some Love This weekend, as I turned back the clocks, searched for my Happy Light, and stared in dismay at the first snowfall of the season, I was reminded that it is the time to give my immune system some extra love. Autumn and winter ā with their requisite cold and…